Newly-released Extracorporeal CO2 Removal Devices Market industry analysis report by Future Market Insights shows that global sales of the Extracorporeal CO2 Removal Devices Market in 2021 were held at US$ 91.6 million. With a CAGR of 5.8% from 2022 to 2032, the market is projected to reach a valuation of US$ 170.9 million by 2032. Extracorporeal CO2 Machines is expected to be the highest revenue-generating category, projected to grow at a CAGR of 6.2% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Extracorporeal CO2 Removal Devices Market (2022) | US$ 97 million |
| Global Extracorporeal CO2 Removal Devices Market (2032) | US$ 170.9 million |
| Global Extracorporeal CO2 Removal Devices Market CAGR (2022 to 2032) | 5.8% |
| The USA Extracorporeal CO2 Removal Devices Market CAGR (2022 to 2032) | 6.1% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Extracorporeal CO2 Removal Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value increased at around 5.6% CAGR, wherein, countries such as Germany, the USA, China, and Japan held a significant share in the global market.
The growing usage of advanced analytics in pharma and medical testing are the key factors influencing the adoption of Extracorporeal CO2 Removal Devices. Owing to this, the market is projected to grow at a CAGR of 5.8% over the coming 10 years.
Health systems and Extracorporeal CO2 Removal Devices enterprises to improve treatment, monetary, and sustainability frameworks while minimizing the costs of healthcare are rapidly adopting analytical solutions. Healthcare financing organizations and government bodies are implementing analytics through claim management and fraud prevention, which is fueling market growth.
The growing elderly population and their increased proclivity for various acute and chronic diseases are likely to drive the expansion of the worldwide extracorporeal carbon dioxide removal market. Furthermore, rising incidences of pulmonary obstructive illness are predicted to aid in the global market's expansion. On the contrary, the risk of infection, hypoxemia, or thrombosis produced by the restricted flow of blood via the circuit may result in severe health issues, posing a long-term challenge to market expansion.
According to the World Health Organization (WHO), around 251 million people worldwide suffer from a chronic pulmonary obstructive condition. The World Health Organization expected that the number of instances of pulmonary obstructive disease would rise due to an increase in smoking among the population, which would raise the global extracorporeal carbon dioxide removal (ECCO2R) device market sales in the coming years.
Furthermore, clinical benefits provided by ECCO2R removal devices, including effective gas exchange, vitalizing blood flow, and strong lung support, are expected to drive the worldwide ECCO2R devices market revenue during the forecast period.
Extracorporeal CO2 removal devices are efficient, safe, and cost-effective. These technologies have been proposed for use in ventilation assistance in clinical settings where they may be effective, such as COPD exacerbation and acute respiratory distress syndrome (ARDS). The rising prevalence of COPD around the world is expected to fuel market expansion.
Extracorporeal CO2 removal devices are an effective therapy for individuals with hypercapnia respiratory failure and may assist clinicians and healthcare partners to improve lung-protective ventilation. These devices can remove enough CO2 to allow for a 50% reduction in alveolar minute ventilation, resulting in a significant reduction in PaCO2. As a result, the multiple benefits connected with these devices are likely to boost the overall market growth.
Principal Consultant
North America is likely to continue to dominate the global extracorporeal CO2 removal market throughout the analysis period, owing to the early adoption of innovations and a large patient pool of COPD and ARDS patients. The increased popularity of novel clinical innovations is attributable to the expansion of the regional market. The spread of chronic respiratory illnesses and the flood of demand for quick and safe minimally intrusive ventilation procedures have accelerated the development of the extracorporeal CO2 removal industry in North America.
The United States has been a pioneer in the Extracorporeal CO2 Removal Devices Market. In recent years, the utilization of Extracorporeal CO2 Removal Devices in the USA expanded due to a growing emphasis on the removal of carbon dioxide in the healthcare sector. The increase in the number of specialized clinics in the United States has also provided new opportunities for market participants.
The market in the United Kingdom is expected to reach a valuation of US$ 62 million by 2032. Growing at a CAGR of 6.1% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 27.5 million.
In Japan, the market is projected to garner an absolute dollar opportunity of US$ 3.3 million with a CAGR of 7.1% during the forecast period. The market in the country is expected to reach a valuation of US$ 6.7 million by 2032.
The market in South Korea is expected to reach a valuation of US$ 4.5 million, growing at a CAGR of 5.7% from 2022 to 2032. The market in the country is expected to witness an absolute dollar opportunity of US$ 1.9 million during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Extracorporeal CO2 machines accounted for over half of the total extracorporeal CO2 removal devices demand. The market for Extracorporeal CO2 Machines is expected to grow at a CAGR of 6.2%. Advancements in technical simplification have allowed the usage of additional corporeal CO2 removal equipment to accelerate dramatically, reducing some of the primary difficulties connected to ECMO. Extracorporeal carbon dioxide removal equipment is theoretically simpler and has comparatively fewer staff needs along with logistical requirements,[mg] as patients may prefer them over ECMO.
The leading players in the extracorporeal CO2 removal system market have used various methods to boost growth potential in the coming years. Collaborations, alliances, mergers, product approvals, and novel product launches are some of the primary methods used by leading companies to create growth avenues in the market.
Some of the key players operating in the market include Medtronic, Getinge AB, Xenios AG, ALung Technologies, ESTOR S.P.A., Medica Spa, and Aferectica Srl.
Some of the recent developments in the key Extracorporeal CO2 Removal Devices Market are as follows:
Similarly, recent developments related to companies offering Extracorporeal CO2 Removal Devices Market have been tracked by the team at Future Market Insights, which are available in the full report.
The global market is worth more than US$ 91.6 million at present.
The market is expected to witness a CAGR of 5.8% from 2022 to 2032.
North America dominated the Extracorporeal CO2 Removal Devices Market. This is attributable to increased spending on procedures and the easy availability of the products.
The market revenue is being driven primarily by the growing healthcare industry, which has consequently accelerated manufacturing
The top 5 countries driving demand for Extracorporeal CO2 Removal Devices Market are the USA, China, Japan, India, the United Kingdom, and South Korea.
Alung Technologies, Inc., Xenios AG, ESTOR S.P.A, Medtronic Plc., Medica S.P.A., and Getinge Group are among the key players operating in the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Future Market Insights Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Extracorporeal CO2 Removal Devices
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2015 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ million) Analysis, 2015 to 2021
7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million) Analysis By Product type, 2015 to 2021
8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Product type, 2022 to 2032
8.3.1. Extracorporeal CO2 Machines
8.3.2. Disposables
8.3.3. Other Product Types
8.4. Market Attractiveness Analysis By Product type
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) Analysis By Application, 2015 to 2021
9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032
9.3.1. Acute Respiratory Distress Syndrome (ARDS)
9.3.2. Chronic Obstructive Pulmonary Disease (COPD)
9.3.3. Bridge to Lung Transplant
9.3.4. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Sample type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) Analysis By Application, 2015 to 2021
10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032
10.3.1. Venovenous
10.3.2. Arteriovenous
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ million) Analysis By Region, 2015 to 2021
11.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
12.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
12.4.1. By Country
12.4.1.1. The USA
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product type
12.4.3. By Application
12.4.4. By Sample type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product type
12.5.3. By Application
12.5.4. By Sample type
13. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product type
13.4.3. By Application
13.4.4. By Sample type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product type
13.5.3. By Application
13.5.4. By Sample type
14. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. The United Kingdom
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product type
14.4.3. By Application
14.4.4. By Sample type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product type
14.5.3. By Application
14.5.4. By Sample type
15. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
15.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product type
15.4.3. By Application
15.4.4. By By Sample type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product type
15.5.3. By Application
15.5.4. By Sample type
16. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2015 to 2021
16.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product type
16.4.3. By Application
16.4.4. By Sample type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product type
16.5.3. By Application
16.5.4. By Sample type
17. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.2.2.1. By Product type
17.2.2.2. By Application
17.2.2.3. By Sample type
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.3.2.1. By Product type
17.3.2.2. By Application
17.3.2.3. By Sample type
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.4.2.1. By Product type
17.4.2.2. By Application
17.4.2.3. By Sample type
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.5.2.1. By Product type
17.5.2.2. By Application
17.5.2.3. By Sample type
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.6.2.1. By Product type
17.6.2.2. By Application
17.6.2.3. By Sample type
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.7.2.1. By Product type
17.7.2.2. By Application
17.7.2.3. By Sample type
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.8.2.1. By Product type
17.8.2.2. By Application
17.8.2.3. By Sample type
17.9. BENELUX Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.9.2.1. By Product type
17.9.2.2. By Application
17.9.2.3. By Sample type
17.10. The United Kingdom Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.10.2.1. By Product type
17.10.2.2. By Application
17.10.2.3. By Sample type
17.11. Nordic Countries Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.11.2.1. By Product type
17.11.2.2. By Application
17.11.2.3. By Sample type
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.12.2.1. By Product type
17.12.2.2. By Application
17.12.2.3. By Sample type
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.13.2.1. By Product type
17.13.2.2. By Application
17.13.2.3. By Sample type
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.14.2.1. By Product type
17.14.2.2. By Application
17.14.2.3. By Sample type
17.15. GCC Countries Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.15.2.1. By Product type
17.15.2.2. By Application
17.15.2.3. By Sample type
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.16.2.1. By Product type
17.16.2.2. By Application
17.16.2.3. By Sample type
17.17. Turkey Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015 to 2032
17.17.2.1. By Product type
17.17.2.2. By Application
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. IBM
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. SYMANTEC
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. MICRO FOCUS
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. QUALYS
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. SOLARWINDS
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. IVANTI
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. MANAGEENGINE
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. CONNECTWISE
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. AVAST
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. AUTOMOX
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Extracorporeal CO2 Removal Devices Market
